Granahan Investment Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-161,130	Closed	-$9.36M	–	191
2024 Q3	$9.36M	Buy	161,130 +16,154	+11%	+$938K	0.37%	83
2024 Q2	$6.63M	Sell	144,976 -4,037	-3%	-$184K	0.27%	102
2024 Q1	$9.86M	Buy	+149,013	New	+$9.86M	0.35%	87